HeartBEATS from Lifelong Learning™

Rare cardiac conditions in pregnancy require early recognition and coordinated care to reduce maternal risk. In this HeartBEATS from Lifelong LearningTM vodcast, cardio-obstetrics experts discuss the diagnosis, risk assessment, and management of rare but high-risk cardiovascular conditions, including pulmonary arterial hypertension, inherited arrhythmia syndromes, cardiomyopathies, and aortopathies. Learners will gain practical insights to support multidisciplinary care and improve outcomes for pregnant and postpartum patients.

Content advisory: This educational vodcast discusses rare cardiac conditions in pregnancy, including clinical scenarios in which pregnancy termination may be considered; the views expressed are those of the individual speakers for educational purposes only and should not be interpreted as positions of the American Heart Association or as medical, legal, ethical, or policy guidance.

Learn more at http://professional.heart.org/maternal-health

Androgen deprivation therapy (ADT) remains foundational in the treatment of prostate cancer. However, prolonged and intensified use of ADT is associated with clinically meaningful cardiovascular (CV) toxicity. This course reviews the major classes of ADT, their mechanisms of action, and the biological pathways linking androgen suppression to CV risk, with emphasis on metabolic dysfunction, vascular injury, and thrombotic risk. Learners will gain practical insight into integrating cardiovascular considerations into prostate cancer management.

Claim CE credit: https://bit.ly/4BmSo0l

Want to know how the new lipidemia guideline will impact your patients? This vodcast breaks down the biggest updates and shows you how to put them into practice. Expert faculty will clarify areas of change and demonstrate how updated guidance can be effectively implemented in everyday patient-centered Hyperlipidemia & ASCVD management.

Claim CE credit: https://bit.ly/47HlhXG

This interactive learning experience is designed to strengthen shingles prevention in practice. Through expert discussion and polling questions, learners will review the burden of disease in at-risk populations, examine evidence on vaccine safety and efficacy, and explore team-based strategies to improve vaccination uptake. Participants will gain practical approaches for addressing barriers and supporting patient-centered care.

Cardiovascular-kidney-metabolic (CKM) syndrome reflects the interconnected relationship among cardiovascular, kidney, and metabolic health. In this vodcast, explore how CKM syndrome staging can help primary care clinicians recognize risk, identify pre-heart failure, and intervene before symptomatic heart failure develops. Watch now to strengthen your approach to early CKM risk identification and prevention.

Metabolic disease is increasingly recognized as a complex, multisystem condition with implications across the liver, cardiovascular system, and beyond. This relevant program guides clinicians through practical strategies to identify and manage metabolic dysfunction, including MASLD/MASH, using accessible tools such as HgA1c, ASCVD risk estimation, CKD staging, and noninvasive fibrosis scores. Our skilled experts highlight newly approved pharmacotherapies and their systemic impact, supporting a more coordinatied, whole-patient approach to care.

Multiple CE credit types available.

This video explores the evolving burden of shingle from epidemiology and clinical impact to risk factors and complications—while also looking ahead to how healthcare systems can shift toward more proactive, prevention-focused strategies to reduce its impact. Claim credit at https://bit.ly/45w36Tu

Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are rapidly increasing in prevalence, driven by rising rates of obesity, insulin resistance, and other metabolic risk factors. Faculty will review zthe physiologic roles of glucagon and incretin receptor signaling and explan how emerging therapies modulate these pathways to improve liver and cardiometabolic outcomes. Join this program to stay current and gain practical guidance to help improve the care of patients with MASLD/MASH.

CE credits available.